69 results
10-K
2023 FY
EX-10.11
VKTX
Viking Therapeutics Inc
Annual report
7 Feb 24
5:24pm
10-Q
2023 Q2
EX-10.1
VKTX
Viking Therapeutics Inc
Quarterly report
26 Jul 23
4:46pm
8-K
EX-10.1
VKTX
Viking Therapeutics Inc
2 Aug 19
Entry into a Material Definitive Agreement
12:00am
10-K
2018 FY
EX-10.14
VKTX
Viking Therapeutics Inc
Annual report
13 Mar 19
5:01pm
10-K
2018 FY
EX-10.15
VKTX
Viking Therapeutics Inc
Annual report
13 Mar 19
5:01pm
8-K
EX-10.3
cg2emujm4mq
29 Sep 17
Viking Therapeutics Announces Purchase Agreements for up to $16.25 Million with Lincoln Park Capital
12:00am
8-K
EX-10.1
4iwtg7bj fq
29 Sep 17
Viking Therapeutics Announces Purchase Agreements for up to $16.25 Million with Lincoln Park Capital
12:00am
8-K
EX-10.2
yn4cnx3zuzq
29 Sep 17
Viking Therapeutics Announces Purchase Agreements for up to $16.25 Million with Lincoln Park Capital
12:00am
8-K
EX-10.1
3irpu2quyoic
19 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
50qj 0aic9p4xdcp6hr2
19 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
9b4ze7qr eo
14 Feb 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
d53w5uhbschj8x8t
25 Aug 16
Viking Therapeutics Enters Into $12.5 Million Common Stock Purchase Agreement with Aspire Capital
12:00am
8-K
EX-10.1
ow2o 0otc8j78hue71dv
15 Mar 16
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.3
twrou44
15 Mar 16
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.2
uay577ml1jt
15 Mar 16
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
740ohmypotjzrdp0kq6
25 Jan 16
Entry into a Material Definitive Agreement
12:00am